The growth of the Sabin strain of type 3 poliovirus is reduced at high temperatures compared to that of its virulent precursor strain Leon. Recombinant viruses have been generated from infectious cDNA clones and demonstrate that the temperature-sensitive (ts) phenotype is mainly attributable to a difference in residue 91 of the virion protein VP3. Examination of non-ts mutants derived in vitro or in vivo reveals the existence of second site mutations some of which are clearly able to suppress the ts phenotype. The location of residue 91 of VP3, and of a number of candidate suppressor mutations, in the atomic structure of the virion suggests that the ts phenotype may result in destabilization of the particle and that the suppressors may function by stabilizing specific interfaces. It is not yet clear whether the ts phenotype is expressed at the level of the particle or in the form of defects in assembly or uncoating of the virion, or all three.
CannA. J.,
StanwayC.,
HughesP. J.,
MinorP. D.,
EvansD. M. A.,
SchildG. C.,
AlmondJ. W.1984; Reversion to virulence of the live attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Research 12:7787–7792
EvansD. M. A.,
DunnG.,
MinorP. D.,
SchildG. C.,
CannA. J.,
StanwayG.,
AlmondJ. W.,
CurreyK.,
MaizelJ. V.Jr1985; A single nucleotide change in the 5′ non-coding region of the genome of the Sabin type 3 poliovaccine is associated with increased neurovirulence. Nature, London 314:548–550
MingL.,
VriendG.,
KamerG.,
MinorI.,
ArnoldE.,
RossmannM. G.,
BoegeU.,
ScrabaD. G.,
DukeG. M.,
PalmenbergA. C.1987; The atomic structure of mengovirus at 3.0 Å resolution. Science 235:182–190
MinorP. D.,
FergusonM.,
EvansD. M. A.,
AlmondI. W.,
IcenogleJ. P.1986a; Antigenic structure of polioviruses of serotypes 1, 2 and 3. Journal of General Virology 67:1283–1291
MinorP. D.,
JohnA.,
FergusonM.,
IcenogleJ. P.1986b; Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. Journal of General Virology 67:693–706
NomotoA.,
OmataT.,
ToyodaH.,
KugeS.,
HorieH.,
KataokaY.,
GenbaY.,
NakanoY.,
ImuraN.1982; Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proceedings of the National Academy of SciencesU.S.A 79:5793–5797
SmithT. J.,
KremerM. S.,
MingL.,
VriendG.,
ArnoldE.,
KamerG.,
RossmannM. G.,
McKinlayM. A.,
DianaG. D.,
OttoM. J.1986; The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233:1286–1293
WestropG. D.,
EvansD. M. A.,
MinorP. D.,
MagrathD.,
SchildG. C.,
AlmondI. W.1986; Investigation of the molecular basis of attenuation in the Sabin type 3 vaccine using novel recombinant polioviruses constructed from infectious cDNA. In The Molecular Biology of Positive Strand VirusesRowlandsD. J.,
MahyB. W. J.,
MayoM. A.
London & Orlando: Academic Press;
World Health Organization Report1981; Markers of poliovirus strains isolated from cases temporally associated with the use of live poliovirus vaccine: report on a WHO collaborative study. Journal of Biological Standardization 9:163–184